Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.5621
-0.0369 (-6.16%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $22.96 million as of August 10, 2026. Its market cap has decreased by -57.92% in one year.
Market Cap
22.96M
Enterprise Value
-26.04M
1-Year Change
-57.92%
Ranking
Category
Stock Price
$0.56
ChartMarket Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $22.96M, a decrease of -96.03%. That is a compound annual growth rate of -45.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 22.96M | -19.68% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tevogen | 27.30M |
| Actuate Therapeutics | 26.44M |
| Evaxion | 25.85M |
| ABVC BioPharma | 25.78M |
| IGC Pharma | 25.68M |
| Actinium Pharmaceuticals | 25.02M |
| Longeveron | 24.20M |
| Allarity Therapeutics | 22.12M |